TRJ-T75

N/A

Report date: 2026/05/18 11:14:40

Base Information

Drug NameTRJ-T75

Drug Alias NameTRJ-T75TRJT75

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-Trop-2CMV replication inhibitors

TargetsTumor-associated calcium signal transducer 2Human cytomegalovirus tripartite terminas

Therapy Area/IndicationsTriple Negative Breast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIsrael

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTrojanBio Ltd

China Registration ClassN/A

Develop Information

Active CompaniesTrojanBio Ltd

Inactive CompaniesN/A

Active IndicationsTriple Negative Breast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A